NCT05623215

Brief Summary

The cementless ATTUNETM Rotating Platform Knee system was compared in a single-blind, randomized RSA trial to its predecessor, the LCS rotating platform Knee System. In this previous study, 61 knees were subjected to RSA examinations at 1-day and 3, 6, 12 and 24 months postoperative. This study found a promising equal migration of both tibial components and a lesser migration of the femoral component of the ATTUNETM knee system after two years, although with a similar migration rate between year 1 and 2. this raises the question of whether the migration of the prostheses relative to each other will increase or remain the same in the long term. To examine this, a mid-and long-term RSA follow-up to measure migration is necessary. In addition, another new RSA measurement parameter has become known in recent years that may provide an indication of the bonding of the prosthesis to the bone at the time of measurement. This new parameter, called the Induced Displacement (ID) of a prosthesis, measures the position and orientation relative to the bone while the prosthesis is under different loading conditions (e.g., patient in supine or standing position). This means that a large measured difference between these different loading condition measurements would indicate that osseointegration of the prosthesis never occurred or is no longer present. To improve the understanding of the tendency of both prostheses to aseptic loosening after a mid- to long-term follow up, migration over time and inducible displacement analyses are necessary. The primary objective of this study is to accurately compare mid- and long-term migration of two uncemented TKR prostheses. The secondary objectives of this study are to evaluate if inducible displacement can be used as a parameter to detect loose implants, and to compare inducible displacement, clinical and radiological outcome and patient-reported outcomes (PROMS) after a follow-up of 5 and 10 years of two uncemented TKR prostheses.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for all trials

Timeline
38mo left

Started Nov 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Nov 2022May 2029

First Submitted

Initial submission to the registry

November 3, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

November 10, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 21, 2022

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2029

Last Updated

April 18, 2024

Status Verified

April 1, 2024

Enrollment Period

6.6 years

First QC Date

November 3, 2022

Last Update Submit

April 16, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline migration of the prostheses

    Migration is measured and expressed in translations, rotations, and MTPM; MTPM is the point of the prosthesis that has moved most.

    5 years post TKA

  • Ten year change from baseline migration of the prostheses

    Migration is measured and expressed in translations, rotations and MTPM; MTPM is the point of the prosthesis that has moved most.

    10 years post TKA

Secondary Outcomes (14)

  • Inducible displacement

    5 years post TKA

  • Inducible displacement

    10 years post TKA

  • EuroQol 5D-5L (EQ-5D-5L)

    5 year post TKA

  • EuroQol 5D-5L (EQ-5D-5L)

    10 year post TKA

  • Knee injury and Osteoarthritis Outcome Scale Physical Function Short-form (KOOS-PS)

    5 year post TKA

  • +9 more secondary outcomes

Other Outcomes (2)

  • Complications

    5 year post TKA

  • Complications

    10 year post TKA

Study Arms (2)

Cementless ATTUNE

Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System

Radiation: Radiographs of the knee for radiostereometric analysis (RSA)

Cementless LCS

Cementless LCS rotating platform Cruciate Sacrificing Knee System

Radiation: Radiographs of the knee for radiostereometric analysis (RSA)

Interventions

RSA radiographs will be made 5 and 10 years after the total knee arthroplasty.

Cementless ATTUNECementless LCS

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this study, all subjects that participated in the initial study (ALknee study - NL58911.058.16) will be asked to participate. All these patients underwent a TKA for symptomatic osteoarthritis of the knee in the period of August 2017 and March 2018 at the Department of Orthopaedics in the Spaarne Gasthuis, Hoofddorp, The Netherlands.

You may qualify if:

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • The Patient participated in the initial study (NL58911.058.16) \[1\].
  • The patient is capable of giving informed consent and expressing a willingness to comply with the study.

You may not qualify if:

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • The patient underwent a major revision TKR (exchange of the tibial or femoral component).
  • The patient is unable or unwilling to sign the informed consent specific to this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaarne Gasthuis

Hoofddorp, North Holland, 2134TM, Netherlands

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Peter A. Nolte, Prof. MD

    Spaarne Gasthuis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
drs

Study Record Dates

First Submitted

November 3, 2022

First Posted

November 21, 2022

Study Start

November 10, 2022

Primary Completion (Estimated)

May 31, 2029

Study Completion (Estimated)

May 31, 2029

Last Updated

April 18, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations